Kura Oncology Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Kura Oncology Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KURA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001422143
Board of directors
-
Carol Schafer · DirectorSince 2023
-
Diane L. Parks · DirectorSince 2023
-
Faheem Hasnain · DirectorSince 2023
-
Helen Louise Collins · DirectorSince 2023
-
Mary T. Szela · DirectorSince 2023
-
Michael Vasconcelles · DirectorSince 2024
-
Thomas Malley · DirectorSince 2023
-
Troy Edward Wilson · Director · President and CEOSince 2023
Chief executives
Troy Edward Wilson
· President and CEO
Dates unknown
Board connections
7 of this board's directors also sit on 13 other boards.
- via Mary T. Szela
- via Troy Edward Wilson
- via Mary T. Szela
- via Thomas Malley
- via Diane L. Parks
- via Helen Louise Collins
- via Faheem Hasnain
- via Carol Schafer
- via Carol Schafer
- via Thomas Malley
- via Troy Edward Wilson
- via Diane L. Parks
- via Mary T. Szela
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,351,000
- 2 purchases by 1 insider
- Sold, last 12 months
- $3,506,271
- 37 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Burrows Francis Officer (Chief Scientific Officer) | Option exercise | +30,000 | $6.15 | $184,500 |
| Sep 24, 2026 | Burrows Francis Officer (Chief Scientific Officer) | Open-market sale | −20,726 | $10.83 | $224,514 |
| Aug 24, 2026 | Troy Edward Wilson Director, Officer (President and CEO) | Open-market purchase | +100,000 | $12.39 | $1,239,000 |
| Aug 21, 2026 | Powl Brian T. Officer (Chief Commercial Officer) | Open-market sale | −4,345 | $11.89 | $51,663 |
| Aug 19, 2026 | Bair Teresa Brophy Officer (Chief Legal Officer) | Open-market sale | −31,487 | $12.63 | $397,681 |
| Aug 17, 2026 | Troy Edward Wilson Director, Officer (President and CEO) | Open-market purchase | +100,000 | $11.12 | $1,112,000 |
| Jun 18, 2026 | Leoni Mollie Officer (Chief Medical Officer) | Open-market sale | −84,929 | $9.82 | $834,003 |
| May 21, 2026 | Powl Brian T. Officer (Chief Commercial Officer) | Open-market sale | −10,000 | $11.00 | $110,000 |
| May 19, 2026 | Powl Brian T. Officer (Chief Commercial Officer) | Open-market sale | −339 | $9.21 | $3,122 |
| May 19, 2026 | FORD KATHLEEN Officer (Chief Operating Officer) | Open-market sale | −2,257 | $9.08 | $20,494 |
| May 18, 2026 | Bair Teresa Brophy Officer (Chief Legal Officer) | Open-market sale | −2,256 | $9.38 | $21,161 |
| Mar 23, 2026 | Troy Edward Wilson Director, Officer (President and CEO) | Option exercise | +6,103 | $6.15 | $37,533 |
| Mar 18, 2026 | Thomas Malley Director | Option exercise | +10,000 | $3.12 | $31,200 |
| Jan 27, 2026 | Powl Brian T. Officer (Chief Commercial Officer) | Open-market sale | −4,842 | $8.46 | $40,963 |
| Jan 27, 2026 | Burrows Francis Officer (Chief Scientific Officer) | Open-market sale | −1,311 | $8.46 | $11,091 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.